Floatz logo

ct125a cells

Mantle Cell Lymphoma (MCL)

Huazhong University of Science and TechnologyCell therapyEarly Phase 1Dormant
C
38/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
81/ 100

Competitive context

173 Active assets in the Mantle Cell Lymphoma (MCL) cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Ruijin Hospital
Phase 4BBB
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Institute (NCI)
Phase 4BBB
Bendamustine
Czech Lymphoma Study Group
Phase 2BBB
Busulphan
City of Hope Medical Center
Phase 2BBB
VINCRISTINE SULFATE
M.D. Anderson Cancer Center
Phase 2BBB

View all 50 →

Same molecule, other indications

ct125a cells is also rated in:

hematopoietic and lymphoid system neoplasmDormant
C
Indicative ·
39 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
C
Indicative ·
39 / 100
View asset →
mature T-cell and NK-cell non-Hodgkin lymphomaDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →